CNBC reported that Bill Ackman bought another 2 million shares of VRX today, saying that “he believed in the company.
When confronted with the Citron allegations of fraud, Valeant said called the report ‘erroneous.’
“There is no sales benefit from any inventory held at these specialty pharmacies and inventory held at the Philidor network pharmacies is reflected in Valeant’s reported inventory levels,” said the release.
In an apparent effort to clarify confusion about the relationship between Philidor and R&O, the company said in the release that “Philidor Rx Services is a pharmacy licensed in Pennsylvania and also provides back-end services, including call center, claims adjudication, IT and logistics support, as well as compliance/HIPPA regulation guidance, to other pharmacies, including R&O Pharmacy.”
Valeant’s shares hit a low of $88 today and have recovered mightily, now trading above $120.
Comments »






